UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
February
19, 2009
Date
of Report (Date of earliest event reported)
|
|
|
ANTIGENICS INC. |
|
(Exact name of registrant as specified in its charter) |
|
DELAWARE |
000-29089 |
06-1562417 |
|
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
|
3 Forbes Road Lexington, MA |
02421 |
|
(Address of principal executive offices) |
(Zip Code) |
781-674-4400
(Registrant’s
telephone number, including area code)
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions (see General Instruction A.2. below):
⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 2.02 |
Results of Operations and Financial Condition |
| On February 19, 2009, Antigenics Inc. announced its financial results for the fourth quarter and year ended December 31, 2008. The full text of the press release issued in connection with the announcement is being furnished as Exhibit 99.1 to this current report on Form 8-K. |
|
Item 9.01 |
Financial Statements and Exhibits | ||
| (d) Exhibits | |||
| The following exhibit is furnished herewith: | |||
| 99.1 | Press Release dated February 19, 2009 | ||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
ANTIGENICS INC. |
||||
| Date: | February 19, 2009 | By: |
/s/ Shalini Sharp |
|
|
Shalini Sharp |
||||
|
Chief Financial Officer |
||||
EXHIBIT INDEX
|
Exhibit No. |
Description of Exhibit |
| 99.1 |
Press Release dated February 19, 2009 |